-+ 0.00%
-+ 0.00%
-+ 0.00%

ATOSSA THERAPEUTICS SELECTS PSI AS CONTRACT RESEARCH ORGANIZATION FOR PIVOTAL DOSE-RANGING STUDY OF (Z)-ENDOXIFEN IN METASTATIC BREAST CANCER

Reuters·08/20/2025 12:30:03

Please log in to view news